394 F.Supp.3d 509
E.D. Pa.2019Background
- This MDL consolidates multiple class and governmental actions alleging that numerous generic-drug manufacturers engaged in a multi‑drug, industry‑wide conspiracy (a "fair share" scheme) to allocate customers, rig bids, and fix or stabilize prices across many generic products.
- Plaintiffs include direct purchasers, end‑payors, indirect resellers, retailers (Kroger), Humana, Marion plaintiffs, and 49 states; complaints allege overlapping defendants, overlapping ANDAs, frequent inter‑firm contacts, employee movement, and coordinated communications at trade events.
- Plaintiffs rely on documentary and testimonial allegations (calls, texts, emails), examples of coordinated price increases across drugs, ANDA overlap, and government investigations and subpoenas, including guilty pleas by two Heritage executives in DOJ prosecutions.
- Defendants moved to dismiss the complaints asserting an overarching multi‑drug conspiracy, arguing plaintiffs failed to plead (1) a single conspiracy beyond individual drug‑specific agreements, (2) interdependence among conspiracies, and (3) sufficient overlap/knowledge by each defendant.
- The Court treated the motions under Twombly/Iqbal pleading standards, considered but declined to adopt Kelly as the exclusive pleading test, and denied the motion to dismiss the overarching‑conspiracy claims, finding plaintiffs alleged sufficient parallel conduct plus “plus factors” (market motive, actions against self‑interest, traditional conspiracy indicia) to survive dismissal.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Sufficiency of pleading under Twombly/Iqbal | Alleged parallel price increases across many drugs plus plus‑factors (communications, trade meetings, DOJ/state investigations) make an overarching conspiracy plausible | Allegations are mere parallel conduct and/or product‑specific conspiracies insufficient to infer a broad agreement | Denied dismissal — Twombly governs; plaintiffs pleaded enough factual matter to make an overarching conspiracy plausible and merit discovery |
| Applicability of United States v. Kelly test | Plaintiffs contend Twombly/Iqbal is the proper pleading framework; some plaintiffs agree Kelly supplies substantive law but not a stricter pleading standard | Defendants urge Kelly’s three factors (common goal, interdependence, participant overlap) should be applied at pleading stage and require dismissal | Court declined to require Kelly at pleading stage but held plaintiffs’ allegations also satisfy Kelly’s factors sufficiently to survive dismissal |
| Existence of a common goal transcending single‑drug agreements | Plaintiffs: defendants shared the goal of avoiding price erosion and maintaining supracompetitive prices across portfolios via a "fair share" code | Defendants: no allegation that each defendant knew or agreed to an industry‑wide scheme; incentives to raise prices for products they did not sell are implausible | Held plausible common goal adequately alleged (e.g., described purpose of "fair share" and examples of cross‑product coordination) |
| Interdependence and overlap among individual conspiracies | Plaintiffs: alleged horse‑trading across drugs, coordinated communications, trade events, employee mobility, ANDA overlap, and investigatory subpoenas showing cross‑product communications | Defendants: individual conspiracies stand alone; mere contacts or overlapping membership are insufficient; plaintiffs must plead how individual conspiracies became one | Held plaintiffs alleged sufficiently detailed connective facts (communications, meetings, employee movement, ANDA overlap, investigations) to plausibly show interdependence and sufficient overlap for discovery to test the theory |
Key Cases Cited
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (establishes plausibility pleading standard for conspiracy claims)
- Ashcroft v. Iqbal, 556 U.S. 662 (affirms Twombly standard: complaints must contain sufficient factual matter to be plausible)
- United States v. Kelly, 892 F.2d 255 (3d Cir. 1989) (articulates three‑factor test for whether conduct reflects a single overarching conspiracy)
- In re Processed Egg Prods. Antitrust Litig., 821 F. Supp. 2d 709 (E.D. Pa. 2011) (discusses viewing a conspiracy as a whole rather than in isolated parts)
- In re Capacitors Antitrust Litig., 106 F. Supp. 3d 1051 (N.D. Cal. 2015) (explains that size/breadth alone does not defeat a conspiracy allegation)
- United States v. Fattah, 914 F.3d 112 (3d Cir. 2019) (on assessing common goal and membership fluidity in conspiratorial enterprises)